Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Published:2016-11-25 Issue:3 Volume:129 Page:382-392
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Devi R.¹,Mali Ghanshyam¹,Chakraborty Indrani¹,Unnikrishnan Mazhuvancherry Kesavan¹,Abdulsalim Suhaj¹²

Affiliation:

1. Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, India

2. Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Buraidah, KSA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2017.1259544

Reference39 articles.

1. Global Status Report on non-communicable diseases 2014. World Health Organization. [cited 2015 Feb 19]. Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf

2. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation; 2013.

3. Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

4. Inhibitors of type 2 sodium glucose co-transporters – a new strategy for diabetes treatment

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of luseogliflozin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;Endocrine;2024-06-17

2. Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study);Indian Journal of Endocrinology and Metabolism;2024-03-08

3. Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis;Cardiovascular Diabetology;2024-01-03

4. Association of SGLT-2 inhibitors with bacterial urinary tract infection in type 2 diabetes;BMC Endocrine Disorders;2023-10-03

5. Efficacy and safety of bexagliflozin in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2023-04-03